Wendy future of retail top

utosomal dominant polycystic kidney disease

PANTHERx selected by Otsuka to distribute Jynarque

PANTHERx selected by Otsuka to distribute Jynarque

PITTSBURGH — PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc.  to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD). PANTHERx is one of just three pharmacies providing nationwide access to the medication. ADPKD is one of the most common, life-threatening genetic diseases, diagnosed

PP_1170x120_10-25-21